ABVX vs IT Comparison

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

Gartner provides independent research and analysis on information technology for chief information officers and other business executives who help plan companies' IT budgets. Its flagship Magic Quadrant reports inform many enterprises of their IT procurement decisions. Gartner also provides consulting services and holds some of the largest conferences in the IT industry. Around 80% of Gartner's revenue is generated from industry research.